Total current assets Total assets Total current liabilities Total liabilities Total stockholders’ equity Balance Balance Total liabilities and stockholders’ equity Total operating expenses Loss from operations Total other income, net Loss before income tax expense Net loss Net loss Total comprehensive loss Total comprehensive loss for the year (in thousands) Total comprehensive losses Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Net cash outflows from operating activities Net cash used in investing activities Net cash provided by financing activities Net (decrease)/increase in cash and cash equivalents Cash and cash equivalents at beginning of period Cash and cash equivalents at end of period Company Overview [Abstract] Ownership [Axis] Basis of Presentation and Summary of Significant Accounting Policies [Abstract] Statement of Financial Position Location, Balance [Axis] Prepaid Expenses and Other Current Assets [Abstract] Total other assets Prepaid expenses and other assets R&D Tax Incentive Receivable [Abstract] Schedule of R&D Tax Incentive Receivable [Abstract] Property, Plant and Equipment, Net [Abstract] Total property, plant and equipment, gross Total property, plant and equipment, net Property, plant and equipment, net Trade and Other Payables, Accrued Expenses and Other Current Liabilities [Abstract] Schedule of Trade and Other Payables, Accrued Expenses and Other Current Liabilities [Abstract] Total trade and other payables Trade and other payables Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Total trade and other payables, accrued expenses and other current liabilities Leases [Abstract] Schedule of Lease Costs [Abstract] Schedule of Future Minimum Lease Payments [Abstract] Total minimum lease payments Commitments and Contingencies [Abstarct] Stockholder’s Equity/Issued Capital [Abstract] Balance Balance Common Stock, shares outstanding Additional Paid-in Capital [Abstract] Opening balance Ending balance General and Administration Expenses [Abstarct] Total general and administration expenses General and administrative Stock-Based Payments [Abstract] Statement of Income Location, Balance [Axis] Numbers of Shares, Unvested and Outstanding Beginning Numbers of Shares, Unvested and Outstanding Ending Numbers of Shares, Unvested Weighted Average Grant Date Fair Value, Unvested and Outstanding Beginning Weighted Average Grant Date Fair Value, Unvested and Outstanding Ending Weighted Average Exercise Price, Unvested Schedule of Stock Options [Abstract] Numbers of Shares, Unvested and Outstanding balance Weighted Average Exercise Price, Unvested and Outstanding balance Aggregate Intrinsic Value, Unvested and Outstanding balance Fair Value of Financial Instruments [Abstract] Class of Warrant or Right [Axis] Income Tax [Abstarct] Schedule of Pre-Tax Accounting Loss from Operations [Abstract] Loss Per Share [Abstract] Schedule of Basic and Diluted Net Loss Per Share Attributable to Stockholders [Abstract] Related Party Transactions [Abstract] Subsequent Events [Abstract] Assets Current assets: Cash and cash equivalents Cash and Cash Equivalent R&D tax incentive receivable Operating lease right-of-use assets Liabilities and stockholders’ equity Current liabilities: Current liabilities Operating lease liabilities, current Operating lease liabilities, non-current Commitments and contingencies (Note 8) Stockholders’ equity: Common stock, $0.0001 par value – 800,000,000 shares authorized; 194,379,996 and 17,642,832 shares issued and outstanding at June 30, 2025 and 2024, respectively Common Stock, par value per share (in Dollars per share) Common stock, par value (in Dollars per share) Common Stock, shares authorized Common stock, shares authorized Common Stock, shares issued Common stock (in Shares) Preferred stock, $0.0001 par value per share, 10,000,000 shares authorized; no shares issued or outstanding at June 30, 2025 and 2024, respectively Preferred stock, par value per share (in Dollars per share) Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Additional paid-in capital Accumulated deficit Foreign currency translation reserve Revenue from customers Operating expenses: Other income, net: R&D tax incentive Foreign exchange expense Interest income Loss on extinguishment Loss on extinguishment ELOC commitment fee Other comprehensive income/ (loss): Currency translation adjustment, net of tax Net loss per share: Basic (in Dollars per share) Net loss per share: diluted (in Dollars per share) Weighted average number of shares outstanding, basic (in Shares) - Weighted average number of Common Stock (number) Weighted average number of shares outstanding, diluted (in Shares) Stock-based compensation Convertible note conversion Issues of new shares – convertible note conversion Share issuance Share issuance (in Shares) Shares issuances (in Shares) Currency translation adjustment, net of tax Convertible note conversion (in Shares) Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Stock-based compensation expense Non-cash expense of ELOC commitment Change in fair value of warrant liabilities Change in fair value of warrant liabilities Change in fair value of Warrants Change in fair value of convertible rights Change in fair value of convertible rights Non-cash interest expense Change in operating assets and liabilities: Trade and other payables Cash flows from investing activities: Cash flows from financing activities: Proceeds received from facility agreement Proceeds share issuance Shares of common stock value Proceeds from issuance of convertible debt Effect of exchange rate changes on cash and cash equivalents Non-cash investing and financing activities Issuance of ELOC warrants at initial fair value Issuance of convertible note warrants at initial fair value Issuance of convertible rights at initial fair value Issuance of Series A warrants at initial fair value Partial conversion of convertible note Total Research and development Interest expense Warrant issuance costs Income tax expense Income tax benefit Share issuance costs Unrealized losses/(gains) on foreign currency remeasurement Prepaid expenses and other current assets R&D tax incentive receivable Purchase of property, plant and equipment Repayment of facility agreement Share issuance costs Warrant issuance costs Cancellation of warrants Repayment of convertible debt Debt issuance costs Common Stock Common Stock [Member] Additional paid-in capital Accumulated deficit Foreign currency translation reserve Company Overview Schedule of Wholly-Owned Subsidiaries Subsidiary Jurisdiction Basis of Presentation and Summary of Significant Accounting Policies Schedule of Data Regarding the Dollar Exchange Rate Exchange rate on balance sheet dates Exchange rate Average exchange rate for the period Prepaid expenses and other current assets Schedule of Prepaid Expenses and Other Current Assets Prepayments GST recoverable R&D tax incentive receivable Schedule of R&D Tax Incentive Receivable Property, Plant and Equipment, net Schedule of Property, Plant and Equipment, Net Furniture, fittings and equipment Assets under construction Trade and other payables, accrued expenses and other current liabilities Schedule of Trade and Other Payables, Accrued Expenses and Other Current Liabilities Trade payables Contract liabilities Accrued expenses Employee leave entitlements Leases Schedule of Lease Costs Lease term (years) Discount rate Operating lease cost Schedule of Future Minimum Lease Payments June 30, 2026 June 30, 2027 June 30, 2028